Lunxi Liang

Lunxi Liang

Auto-generated profile, based on publicly available information

Lunxi Liang

Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2019 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
HYHan Yao
Han Yao
JLJiang Lan
Jiang Lan
CLChushu Li
Chushu Li
Hubing ShiHubing Shi
Hubing Shi
JBJean-Philippe Brosseau
Jean-Philippe Brosseau
JXJie Xu
Jie Xu

5 November 2018 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
HWHuanbin Wang
Huanbin Wang
HYHan Yao
Han Yao
CLChushu Li
Chushu Li
Hubing ShiHubing Shi
Hubing Shi
JLJiang Lan
Jiang Lan
JXJie Xu
Jie Xu

15 June 2015 in Oncogene
Verified
Journal Article
Closed access
LLL Liang
L Liang
JFJ-Y Fang
J-Y Fang
JXJ Xu
J Xu

30 June 2015 in Scientific Reports
Verified
Journal Article
Open access
LLLunxi Liang
Lunxi Liang
LALuoyan Ai
Luoyan Ai
JQJin Qian
Jin Qian
JFJingyuan Fang
Jingyuan Fang
JXJie Xu
Jie Xu
The gut microbiota is commonly referred to as a hidden organ due to its pivotal effects on host physiology, metabolism, nutrition and immunity. The gut microbes may be shaped by environmental and host genetic factors and previous studies have focused on the roles of protein-coding genes. Here we show a link between long non-coding RNA (lncRNA) expression and gut microbes. By repurposing exon microarrays and comparing the lncRNA expression profiles between germ-free, conventional and different gnotobiotic mice, we revealed subgroups of lncRNAs that were specifically enriched in each condition. A nearest shrunken centroid methodology was applied to obtain lncRNA-based signatures to identify mice in different conditions. The lncRNA-based prediction model successfully identified different gnotobiotic mice from conventional and germ-free mice and also discriminated mice harboring transplanted microbes from fecal samples of mice or zebra fishes. To achieve optimal prediction accuracy, fewer lncRNAs were required in the prediction model than protein-coding genes. Taken together, our study demonstrated the effecacy of lncRNA expression profiles in discriminating the types of microbes in the gut. These results also provide a resource of gut microbe-associated lncRNAs for the development of lncRNA biomarkers and the identification of functional lncRNAs in host-microbes interactions.

15 June 2023 in Microbiology Spectrum
Verified
Journal Article
Open access
XLXin-Meng Li
Xin-Meng Li
XSXiao Shi
Xiao Shi
YYYao Yao
Yao Yao
YSYi-Cun Shen
Yi-Cun Shen
XWXiang-Ling Wu
Xiang-Ling Wu
FWFen Wang
Fen Wang
The study of gut bacteria has become increasingly popular, and fecal sample preservation methods and times need to be standardized. Here, we detail a 12-month study of fecal sample preservation, and our study provides an empirical reference about experimental details for long-term high-quality storage of fecal samples in the field of gut microbiology research.

16 May 2017 in OncoImmunology
Verified
Journal Article
Open access
HWHuanbin Wang
Huanbin Wang
HYHan Yao
Han Yao
CLChushu Li
Chushu Li
LLLunxi Liang
Lunxi Liang
YZYao Zhang
Yao Zhang
JXJie Xu
Jie Xu
Colorectal cancer (CRC) is the second leading cause of cancer death worldwide, and immune checkpoint blockade therapy provides an opportunity for improving the outcome of CRC patients. Recent studies suggest that programmed death ligand-1 (PD-L1) is only expressed in 12% of CRCs. Here, we demonstrate that PD-L2 is expressed in approximately 40% CRCs, and its expression independently associates with poor survival of CRC patients. By detection of PD-L2 expression by immunofluorescence in 124 CRC cases with 10-y survival data, we found significant association between PD-L2 overexpression in cancer cells and worse overall survival (46.3 vs 69.1 mo; p = 0.0004). The association remained significant in multivariate COX regression analysis (hazard ratio = 2.778, 95% confidence interval [CI] = 1.668–4.627; p < 0.0001). In the validation CRC data set, significant association between PD-L2 overexpression and poor survival was supported by the univariate analysis (27.1 vs. 88.9 mo; p = 0.0002) and multivariate model (hazard ratio = 7.09, 95%CI 1.78–28.16; p = 0.005). Western Blot revealed strong induction of PD-L2 expression by interferon-γ (IFNγ) in CRC cells, and the mRNA levels of both genes were significantly correlated in CRC tissue samples. Suppression of glycosylation with tunicamycin caused a shift in molecular weight and significant decrease in the expression of PD-L2 protein. In conclusion, PD-L2 overexpression in CRC cells, under the regulation by IFNγ and glycosylation, associates with poor survival of patients with colorectal cancer. These findings highlight PD-L2 as a promising therapeutic target in CRC and suggest potential routes to control PD-L2 expression in CRC cells.